Simplex Trading’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Simplex Trading’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-3,621	Closed	-$1.82K	–	7257
2016 Q3	$1K	Buy	3,621 +2,400	+197%	+$1.1K	﹤0.01%	5682
2016 Q2	$0	Sell	1,221 -2,800	-70%	-$2.99K	﹤0.01%	7112
2016 Q1	$5K	Buy	+4,021	New	+$7.93K	﹤0.01%	4198
2015 Q2	–	Sell	-56	Closed	-$490	–	6587
2015 Q1	$0	Sell	56 -3,268	-98%	-$22K	﹤0.01%	6389
2014 Q4	$18K	Buy	+3,324	New	+$17K	﹤0.01%	2166

Other funds holding NWBO

Montecito Bank & Trust Santa Barbara, California $660M AUM 18.73% 1-Year Est. Return

Whalerock Point Partners Providence, Rhode Island $587M AUM 29.61% 1-Year Est. Return

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Simplex Trading's NWBO Position: Q4 2016 in Review

Simplex Trading sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 3,621 shares — an estimated $1.82K sold.

Simplex Trading first reported a position in NWBO in Q4 2014 and held it in 5 quarters. The position peaked at $18K in Q4 2014. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

Simplex Trading reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
Simplex Trading sold 3,621 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $1.82K.
Simplex Trading first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2014 and held it in 5 quarters.
Simplex Trading's Northwest Biotherapeutics, Inc. Common stock position peaked at $18K in Q4 2014.
8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.